Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca    AZN   GB0009895292

ASTRAZENECA

(AZN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo AstraZeneca
AstraZeneca is one of the world's leading pharmaceutical groups. Net sales break down by treatment area as follows:

- cardiovascular and metabolic diseases (32.3%);

- respiratory diseases (20.9%);

- oncology (17.9%);

- other (18.5%): inflammatory and autoimmune diseases, neurological diseases, gastrointestinal and infectious diseases.

The remaining sales (10.4%) concern primarily research and study services provided for third parties.

Net sales are distributed geographically as follows: the United Kingdom (2.4%), Continental Europe (23.4%), Americas (37.1%) and Africa/Asia/Australia (37.1%).
Managers
NameAgeSinceTitle
Pascal Soriot592012Chief Executive Officer & Executive Director
Leif Johansson672012Non-Executive Chairman
Pam P. Cheng, MBA482015Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer, MBA672013Chief Financial Officer & Executive Director
Shriti Vadera572011Independent Non-Executive Director
Graham Andrew Chipchase562012Senior Independent Non-Executive Director
Geneviéve B. Berger MD, PhD642012Independent Non-Executive Director
Philip Arthur John Broadley582017Director
Nazneen Rahman, PhD-2017Non-Executive Director
Sherilyn S. McCoy, MBA602017Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 1,311,776,898 1,307,532,120 99.7% 0 0.0% 99.7%
Shareholders
NameEquities%
Investor AB (Investment Company) 51,587,810 4.07%
BlackRock Investment Management (UK) Ltd. 51,441,535 4.06%
Capital Research & Management Co. (World Investors) 45,026,061 3.55%
The Vanguard Group, Inc. 38,897,412 3.07%
Legal & General Investment Management Ltd. 29,388,000 2.32%
Norges Bank Investment Management 26,683,000 2.11%
BlackRock Fund Advisors 23,972,063 1.89%
Dodge & Cox 18,860,000 1.49%
Fidelity Management & Research Co. 18,806,000 1.48%
BlackRock Advisors (UK) Ltd. 13,938,407 1.10%
Holdings
NameEquities%Valuation
Swedish Orphan Biovitrum (SOBI) 24,193,0928.85%519,806,485 USD
Astrazeneca Pharma India Ltd (506820) 18,750,00075.0%389,945,813 USD
Moderna Inc (MRNA) 25,499,3257.75%389,374,693 USD
Innate Pharma (IPH) 6,260,5009.80%53,209,993 USD
Circassia Pharmaceuticals Plc 71,081,21719.9%43,454,080 USD
Albireo Pharma Inc (ALBO) 508,1414.25%12,464,699 USD
PhaseBio Pharmaceuticals Inc (PHAS) 3,004,55412.3%9,284,072 USD
Entasis Therapeutics Holdings Inc (ETTX) 2,164,85516.5%8,810,960 USD
Millendo Therapeutics Inc (MLND) 356,0892.76%2,830,908 USD
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, OMX Stockholm 30, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- Bloomberg Code :  AZN:LN
- Reuters Code :  AZN.L
- Datastream Code :  AZN
Company contact information
AstraZeneca
1 Francis Crick Avenue
CB2 0AA Cambridge, Cambridgeshire
United Kingdom

Phone : +44 (0)20 3749 5000
Fax : +44 (0)20 7604 8151
Internet : http://www.astrazeneca.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of AstraZeneca
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ASTRAZENECA9.82%98 485
JOHNSON & JOHNSON8.66%348 981
PFIZER-1.33%233 072
ROCHE HOLDING LTD.14.63%227 848
NOVARTIS22.44%220 893
MERCK AND COMPANY10.57%206 641
ELI LILLY AND COMPANY-0.92%113 364
ABBVIE-15.82%111 910
AMGEN-6.71%105 129
SANOFI2.93%103 743
GLAXOSMITHKLINE7.63%97 904
NOVO NORDISK AS16.38%91 011
BRISTOL-MYERS SQUIBB COMPANY-8.06%75 440
CELGENE CORPORATION51.58%66 725
BAYER AG-9.13%56 539
TAKEDA PHARMACEUTICAL CO LTD5.61%51 782
JIANGSU HENGRUI MEDICINE CO.22.05%40 485
ALLERGAN PLC-9.74%40 362
CHUGAI PHARMACEUTICAL CO LTD14.24%37 224
DAIICHI SANKYO COMPANY, LIMITED76.32%35 780
ASTELLAS PHARMA INC8.69%25 754
Connections : AstraZeneca
Firmenich SA
Glaziers Hall Ltd.
The Takeover Panel
BrightSphere, Inc.
Eastbourne College
The Partnership for New York City
AstraZeneca UK Ltd.
Ericsson AB
National Quality Forum
Certara USA, Inc.
Pharmaceutical Research & Manufacturers of America
Ecolean AB
Santander UK Group Holdings Plc
Boao Forum For Asia
Santander UK Plc (Private Equity)
Astrazeneca Intermediate Holdings Ltd.
Stallergenes Greer Plc
Stonehill College, Inc.
Föreningen Teknikföretagen i Sverige
Catalyst, Inc.
Orchard Therapeutics (Europe) Ltd.
Rutgers State University of New Jersey
AstraZeneca AB